Factors influencing postoperative recurrence of early-stage non-small cell lung cancer

被引:2
|
作者
Akcam, Tevfik Ilker [1 ]
Tekneci, Ahmet Kayahan [2 ]
Ergin, Tiffany Melissa [1 ]
Memmedov, Rza [1 ]
Ergonul, Ayse Gul [1 ]
Ozdil, Ali [1 ]
Turhan, Kutsal [1 ]
Cakan, Alpaslan [1 ]
Cagirici, Ufuk [1 ]
机构
[1] Ege Univ, Dept Thorac Surg, Sch Med, Izmir, Turkiye
[2] Hlth Sci Univ Izmir, Tepecik Educ & Res Hosp, Dept Thorac Surg, Izmir, Turkiye
关键词
Non-small cell lung cancer; recurrence; survival; histopathology; STAS; surgery; PROGNOSTIC IMPACT; 2; CM; RESECTION; ADENOCARCINOMA; IA; CLASSIFICATION; LOBECTOMY; INVASION; PATTERN;
D O I
10.1080/00015458.2023.2231210
中图分类号
R61 [外科手术学];
学科分类号
摘要
PurposeThis study aims to explain the factors that may influence recurrence after surgical resection for early non-small cell lung cancer (NSCLC).MethodsA retrospective analysis was made of 302 patients who underwent lung resection for stage I-IIA NSCLC in our clinic between January 2014 and August 2021.ResultsThe recurrence rate was higher in patients with squamous cell carcinoma (SCC) than in those with adenocarcinoma (AC) (p = 0.004). Disease-free survival (DFS) was shorter in SCC (p = 0.004). According to histopathological subtypes, the presence of lymphovascular invasion (LVI), vascular invasion (VI), visceral pleural invasion (VPI) and tumor spread through air spaces (STAS) caused an increased risk of recurrence ((p = 0.004), (p = 0.001), (p = 0.047), (p = < 0.001)) and shorter DFS ((p = 0.002), (p = < 0.001), (p = 0.038), (p = < 0.001)). LVI and VI was more common in patients with distant recurrence (p = 0.020, p = 0.002), while the STAS was more common with locoregional recurrence (p = 0.003).ConclusionThe presence of LVI, VI, VPI, and STAS are negative risk factors for recurrence and DFS in all patients and in patients with AC. In patients with SCC, the diagnosis of SCC itself and the presence of STAS were risk factors for recurrence and DFS. Moreover, the risk of distant recurrence is higher in the presence of LVI or VI, and the risk of locoregional recurrence in the presence of STAS is higher.
引用
收藏
页码:121 / 130
页数:10
相关论文
共 50 条
  • [1] EARLY-STAGE NON-SMALL CELL LUNG CANCER STRATIFYING RECURRENCE RISK
    Saito, T.
    Kono, Y.
    Ueno, Y.
    Maru, N.
    Utsumi, T.
    Matsui, H.
    Taniguchi, Y.
    Hino, H.
    Tsuta, K.
    Honda, O.
    Murakawa, T.
    JOURNAL OF THORACIC ONCOLOGY, 2024, 19 (10) : S559 - S560
  • [2] Factors influencing patient satisfaction after treatments for early-stage non-small cell lung cancer
    Cecilia Pompili
    Sanjush Dalmia
    Finn McLennan Battleday
    Zoe Rogers
    Kate Absolom
    Hilary Bekker
    Kevin Franks
    Alex Brunelli
    Galina Velikova
    Journal of Cancer Research and Clinical Oncology, 2022, 148 : 2447 - 2454
  • [3] Factors influencing patient satisfaction after treatments for early-stage non-small cell lung cancer
    Pompili, Cecilia
    Dalmia, Sanjush
    McLennan Battleday, Finn
    Rogers, Zoe
    Absolom, Kate
    Bekker, Hilary
    Franks, Kevin
    Brunelli, Alex
    Velikova, Galina
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2022, 148 (09) : 2447 - 2454
  • [4] Lung Tissue Transcriptome as Predictor of Recurrence in Early-stage Non-small Cell Lung Cancer
    Darawshy, F.
    Dolgalev, I.
    Wu, B. G.
    Li, Y.
    Kwok, B.
    Schluger, R.
    Sulaiman, I.
    Tsirigos, A.
    Moreira, A.
    Pass, H.
    Tsay, J. J.
    Segal, L. N.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2023, 207
  • [5] Factors Affecting Tumor Recurrence in Early Stage Non-Small Cell Lung Cancer
    Duma, Narjust
    Castro, Yulanka
    Harper, Harry D.
    Gutierrez, Martin
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S668 - S668
  • [6] Factors Affecting Tumor Recurrence in Early Stage Non-small Cell Lung Cancer
    Duma, Narjust
    Dominguez, Yulanka Castro
    Harper, Harry
    Gutierrez, Martin
    CHEST, 2015, 148 (04)
  • [7] Social factors, treatment, and survival in early-stage non-small cell lung cancer
    Greenwald, HP
    Polissar, NL
    Borgatta, EF
    McCorkle, R
    Goodman, G
    AMERICAN JOURNAL OF PUBLIC HEALTH, 1998, 88 (11) : 1681 - 1684
  • [8] Postoperative adjuvant therapy for completely resected early-stage non-small cell lung cancer
    Harubumi Kato
    Masahiro Tsuboi
    Yasufumi Kato
    Norihiko Ikeda
    Tetsuya Okunaka
    Chikuma Hamada
    International Journal of Clinical Oncology, 2005, 10 (3) : 157 - 164
  • [9] Postoperative Recurrence of Early-Stage Non-Small Cell Lung Cancer (NSCLC): Clinical Outcomes of Oligo versus Poly-recurrence Disease
    Giorlando, M.
    Mansilla, D.
    Cresta Morgado, P.
    Gabay, C.
    Castro, M.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (03) : S356 - S357
  • [10] Adjuvant Therapy in Early-Stage Non-Small Cell Lung Cancer
    Serke, Monika
    CONTROVERSIES IN TREATMENT OF LUNG CANCER, 2010, 42 : 135 - 144